Tetra Bio Pharma gets FDA clearance on IND for QIXLEEF, creates new subsidiary



Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) CEO Guy Chamberland tells Proactive the FDA has cleared its investigational new drug application on its …

Be the first to comment

Leave a Reply

Your email address will not be published.


*